RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Global Harmonization Initiatives

In Focus: Global Harmonization Initiatives

Posted 01 March 2010

The steadily increasing push for drug and device regulatory harmonization worldwide has been driven by many factors, not the least of them economic. It is no longer possible for a country to exist in a bubble, unconcerned about socioeconomic, political and regulatory developments in faraway regions. Neither is it feasible for a pharmaceutical or medical device company to ignore the regulatory infrastructure and requirements of other countries simply because it is not currently importing into or exporting from these areas. This situation could change rapidly.


© 2022 Regulatory Affairs Professionals Society.